Compare TBPH & ODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TBPH | ODD |
|---|---|---|
| Founded | 2013 | 2018 |
| Country | United States | Israel |
| Employees | N/A | 658 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 824.9M | 688.4M |
| IPO Year | 2013 | 2022 |
| Metric | TBPH | ODD |
|---|---|---|
| Price | $16.47 | $11.93 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 11 |
| Target Price | $18.40 | ★ $41.00 |
| AVG Volume (30 Days) | 288.8K | ★ 1.3M |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 279.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,386,000.00 | N/A |
| Revenue This Year | $8.46 | N/A |
| Revenue Next Year | N/A | $22.92 |
| P/E Ratio | ★ N/A | $16.73 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.10 | $10.80 |
| 52 Week High | $21.03 | $79.18 |
| Indicator | TBPH | ODD |
|---|---|---|
| Relative Strength Index (RSI) | 51.14 | 33.27 |
| Support Level | $16.14 | $10.80 |
| Resistance Level | $17.21 | $16.04 |
| Average True Range (ATR) | 0.38 | 0.89 |
| MACD | -0.06 | -0.19 |
| Stochastic Oscillator | 47.84 | 8.30 |
Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.
ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage. Geographically, the company generates majority revenue from United states followed by other countries and Israel.